Dr Peter FitzGerald named as Irish Times Business Person of the Month
Randox Laboratories are pleased to announce that Managing Director Dr Peter FitzGerald has been named as the Irish Times’ Business Person of the Month for February 2018.
The award follows an announcement from Randox that the company will be investing £50m into three new Centres of Excellence in Northern Ireland, which will deliver cutting-edge technologies to diagnose conditions like cancer, heart conditions and infectious diseases.
At the time of the announcement, Dr FitzGerald commented;
“Enabling earlier and more accurate diagnosis, to identify those at the earliest stages of illness, ideally before the onset of any symptoms, is a game-changer. Through early intervention we can restrict the development of chronic conditions and improve people’s lives. Our view of the future is one where people are empowered through earlier diagnosis to stay healthier for longer, and where healthcare systems are freed to deliver quality services to patients. Our announcement today demonstrates our continuing commitment in this field.”
Scientists from the Antrim-headquartered group will work collaboratively with researchers and scientists from both Queen’s University and Ulster University in the new centres, which were launched at the new Randox Science Park by Sir John Bell.
In addition to the Randox Science Park, Randox has manufacturing, and research and development operations in Antrim, Donegal, India and the United States, and employs more than 1400 people across the globe.
Having been focused in the field of clinical diagnostics for over 36 years, Randox has a successful track record of developing new and innovative tests – examples include assessing those at risk of Alzheimer’s disease and genetic cardiac conditions, to promote and enable preventive treatment, and a new clinically-approved test to diagnose prediabetes.
Each year 5% of the world’s population – more than 370 million people in 145 countries – receive a health diagnosis via a product manufactured by Randox.
For further information please contact the Randox PR team by emailing randoxpr@randox.com or phoning 028 9442 2413.
